Clinics in Rhode Island
By the PeptideAgent Editorial Team. Draft, pending editorial review. Last verified
What Rhode Island law means for peptide clinics: who may prescribe, whether pharmacies may compound GLP-1 drugs (limited), how to check a clinic, and verified listings.
Rhode Island at a glance
- Pharmacy regulator
- Rhode Island Board of Pharmacy (Rhode Island Department of Health)
- 503A framework
- Follows the federal 503A framework
- Telehealth prescribing
- Regulatory: Telehealth allowed
- Asynchronous prescribing
- Regulatory: Async unclear
- Compounded GLP-1 access
- Regulatory: Compounded GLP-1 limited
Verified clinics serving Rhode Island
No verified clinics serving Rhode Island are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.
Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.
Run a pharmacy, clinic, or telehealth service? Apply for a listing.
Peptide access rules in Rhode Island
Yes. A Rhode Island resident can obtain FDA approved peptides such as semaglutide and tirzepatide from any Rhode Island-licensed prescriber, including through telemedicine under Rhode Island General Laws section 5-37-22 and the Telemedicine Coverage Act (chapter 27-81), and can obtain a compounded peptide when it is eligible under federal 503A rules and dispensed by a pharmacy licensed by the Rhode Island Department of Health, which houses the Board of Pharmacy, or holding a Rhode Island nonresident pharmacy license. Rhode Island has no state bulks list, so eligibility of a peptide for compounding follows the FDA framework, and the Department of Health's pharmacy regulations (216-RICR-40-15) govern how licensed pharmacies compound. [1] [2] [3] [4] [5] [6] [7] [9] [12]
Compounded GLP-1 access in Rhode Island
Telehealth GLP-1 patients should confirm the dispensing pharmacy holds a Rhode Island pharmacy or nonresident pharmacy license. [1] [10]
Research use only sellers in Rhode Island
Rhode Island General Laws chapter 5-19.1 restricts dispensing of prescription drugs to licensed pharmacies, and the Rhode Island Food, Drugs, and Cosmetics Act (chapter 21-31) prohibits the sale of adulterated, misbranded, or unapproved new drugs in the state. [5] [8] [11]
How to check a clinic in Rhode Island
- Confirm the prescribing clinician's license with the Rhode Island medical or nursing board.
- Ask which pharmacy compounds or dispenses the peptide and check it in the Rhode Island Board of Pharmacy (Rhode Island Department of Health) license lookup. [2] [5] [6] [7] [9]
- Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
- Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Rhode Island. [5] [8] [11]
Common questions in Rhode Island
Can I get a GLP-1 prescription in Rhode Island through telemedicine?
Yes. Section 5-37-22 allows a Rhode Island-licensed physician to establish a relationship and prescribe through telemedicine when the care meets the in-person standard. Semaglutide and tirzepatide are not controlled substances, so no separate in-person requirement applies. [3] [4]
Does the telemedicine prescriber need a Rhode Island license?
Yes. Section 5-37-22 applies to physicians licensed in Rhode Island, and the Department of Health licenses nurse practitioners and physician assistants who prescribe. Rhode Island is a member of the Interstate Medical Licensure Compact. Verify the prescriber in the Department of Health license lookup before paying. [1] [3] [12]
Sources
- [1]Rhode Island Department of Health (Board of Pharmacy and professional licensing)
- [2]Rhode Island Department of Health: Pharmacy licensing (Board of Pharmacy)
- [3]Rhode Island General Laws section 5-37-22, Telemedicine
- [4]Rhode Island General Laws chapter 27-81, Telemedicine Coverage Act
- [5]Rhode Island General Laws chapter 5-19.1, Pharmacies
- [6]Rhode Island General Laws section 5-19.1-11, Nonresident pharmacy
- [7]216-RICR-40-15-1, Pharmacists, Pharmacies, and Manufacturers, Wholesalers, and Distributors (Rhode Island Department of Health regulations)
- [8]Rhode Island General Laws chapter 21-31, Rhode Island Food, Drugs, and Cosmetics Act
- [9]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
- [10]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
- [11]21 U.S.C. 331, Prohibited acts
- [12]Interstate Medical Licensure Compact Commission: participating states